Clinical Trials Directory

Trials / Conditions / Pancreatic Adenocarcinoma Resectable

Pancreatic Adenocarcinoma Resectable

8 registered clinical trials studyying Pancreatic Adenocarcinoma Resectable — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingAdjuvant Pancreatic Therapy Guided by MRD
NCT06966440
Ruijin HospitalN/A
WithdrawnA Pilot Study of IRE for Resectable Pancreatic Cancer
NCT03337997
University of SaskatchewanN/A
WithdrawnHigh Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM)
NCT03697239
Hitendra PatelPhase 1 / Phase 2
WithdrawnHigh Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM)
NCT03908333
Medical College of WisconsinPhase 1 / Phase 2
CompletedSequential Use of AG and mFOLFIRINOX as Neoadjuvant Chemotherapy for Resectable Pancreatic Cancer
NCT03750669
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase 3
CompletedTrial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM)
NCT03410030
HonorHealth Research InstitutePhase 1 / Phase 2
CompletedEffect on Tumor Perfusion of a Chemotherapy Combining Gemcitabine and Nab-paclitaxel (Abraxane) in Pancreatic
NCT01715142
Jean-Luc Van LaethemEARLY_Phase 1
UnknownEffect on Tumor Perfusion of a Chemotherapy Combining Gemcitabine and Vismodegib Before Surgery in Pancreatic
NCT01713218
Jean-Luc Van LaethemEARLY_Phase 1